Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Maintains Neutral on Helmerich & Payne, Lowers Price Target to $36

Author: Benzinga Newsdesk | July 15, 2024 07:23am
Piper Sandler analyst Ian Macpherson maintains Helmerich & Payne (NYSE:HP) with a Neutral and lowers the price target from $39 to $36.

Posted In: HP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist